Reported Nov 7, 2018 · Terminated
Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC…
Pharm D Solutions, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Pharm D Solutions, LLC · 1304 S Loop W · Houston, TX · 77054-4010
Is this the product you have?
- Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas
- Lot codes and dates
- Lota) 09062018:87
- Discard by1/14/2019
- b) 0404201844
- Discard by
10/29/201809022018:04
- Discard by
3/1/201905212018:44
- Discard by
11/17/201806122018:83
- Discard by
12/9/201808132018:86
- Discard by2/9/2019
- Amount recalled
- 609 vials
This recall covers 79 products
The agency filed one notice per product. You are reading one of them; the other 78 are below.
66 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Pharm D Solutions, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.